Sanofi (SAN) Ordinary Euro 2
Sell:€92.20Buy:€93.30
€2.30
(2.53%)
Paris CAC 40:
0.58%
0.58%Market closed | Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:€92.20
Buy:€93.30
Change:€2.30
(2.53%)
€2.30
(2.53%)Market closed | Prices delayed by at least 15 minutes
Sell:€92.20
Buy:€93.30
Change:€2.30
(2.53%)
€2.30
(2.53%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 31 October 2024 | Clotilde DelbosIndependent Director | Buy Regular purchase transaction | 500 | €97.53 | €48,765.00 | 500 |
| 16 September 2024 | Anne-Francoise NesmesIndependent Director | Buy Regular purchase transaction | 533 | £87.02 | £46,380.17 | 533 |
| 21 June 2024 | John S. SundyIndependent Director | Buy Regular purchase transaction | 887 | $46.94 | $41,638.17 | 887 |
| 26 April 2024 | Antoine Jean YverIndependent Director | Buy Regular purchase transaction | 1,000 | €91.38 | €91,380.00 | 1,000 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 26 April 2024 | Antoine Jean YverIndependent Director | Buy Regular purchase transaction | 1,000 | €91.38 | €91,380.00 | 1,000 |
| 31 October 2024 | Clotilde DelbosIndependent Director | Buy Regular purchase transaction | 500 | €97.53 | €48,765.00 | 500 |
| 16 September 2024 | Anne-Francoise NesmesIndependent Director | Buy Regular purchase transaction | 533 | £87.02 | £46,380.17 | 533 |
| 21 June 2024 | John S. SundyIndependent Director | Buy Regular purchase transaction | 887 | $46.94 | $41,638.17 | 887 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.